Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
ONE-ALPHA CHEPLAPHARM ARZNEIMITTEL GMBH Actual shortage 2MCG Updated Report 2024-09-16 213256
INHIBACE PLUS CHEPLAPHARM ARZNEIMITTEL GMBH Actual shortage 12.5MG 5MG Updated Report 2024-09-16 230712
MICAFUNGIN SODIUM FOR INJECTION HIKMA CANADA LIMITED Actual shortage 100MG New Report 2024-09-16 237779
LACTATED RINGER'S INJECTION ICU MEDICAL CANADA INC Actual shortage 3.1MG 0.2MG 0.3MG 6MG Updated Report 2024-09-16 228396
SODIUM CHLORIDE INJECTION USP ICU MEDICAL CANADA INC Actual shortage 9MG Updated Report 2024-09-16 235358
LOXAPAC IM SANDOZ CANADA INCORPORATED Actual shortage 50MG Updated Report 2024-09-16 236567
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Anticipated shortage 4.5MG New Report 2024-09-16 237768
SANDOZ RIVASTIGMINE SANDOZ CANADA INCORPORATED Anticipated shortage 3MG New Report 2024-09-16 237764
SANDOZ FESOTERODINE FUMARATE SANDOZ CANADA INCORPORATED Anticipated shortage 8MG New Report 2024-09-16 237761
SANDOZ TOLTERODINE LA SANDOZ CANADA INCORPORATED Anticipated shortage 4MG New Report 2024-09-16 237757

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
HUMULIN R ELI LILLY CANADA INC To be discontinued 100UNIT Updated Report 2024-09-16 224344
TARO-DIPYRIDAMOLE/ ASA TARO PHARMACEUTICALS INC Discontinued 25MG 200MG New Report 2024-09-09 237043
HUMALOG ELI LILLY CANADA INC To be discontinued 100UNIT Updated Report 2024-09-05 224347
GLUCONORM 2.0MG NOVO NORDISK CANADA INC Discontinued 2.0MG Updated Report 2024-09-05 201489
LEVOPHED PFIZER CANADA ULC Discontinued 1MG Updated Report 2024-08-29 236113
FLAREX NOVARTIS PHARMACEUTICALS CANADA INC To be discontinued 0.1% New Report 2024-08-27 235987
PMS-SOTALOL - 160 MG PHARMASCIENCE INC Reversed 160MG Updated Report 2024-08-23 234583
PIPERACILLIN AND TAZOBACTAM FOR INJECTION FRESENIUS KABI CANADA LTD Discontinued 4.5G 36G Updated Report 2024-08-20 235203
OESCLIM SEARCHLIGHT PHARMA INC Discontinued 50MCG Updated Report 2024-08-19 234662
OESCLIM SEARCHLIGHT PHARMA INC Discontinued 25MCG Updated Report 2024-08-19 234118